Search
forResearch 10 of 1000+
- Hair relaxer use and breast cancer risk by tumor molecular subtypes.
- 0750 Proteomics and transcriptomics profiling define molecular subtypes of advanced cutaneous T cell lymphoma and prognostic biomarkers
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- 414 A fitst-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and fluorescence contrast in skin cancer
- Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease Pathways
- 311 Single-cell transcriptomics reveals distinct molecular programs in folliculotropic mycosis fungoides
- Mutations in KLHL24 Add to the Molecular Heterogeneity of Epidermolysis Bullosa Simplex
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Drugs targeting epithelial–mesenchymal transition molecules for treatment of lichen planopilaris
- Revising the role of the androgen receptor in breast cancer
Community 9 of 33
- Molecule PP405: A Research Team Backed By Google Ventures Has Discovered One Of The Most Promising Solutions For Hair Loss To Date
- Another molecular pathway to promote scarless healing and regenerate hair follicles
- Intriguing Molecular Structures and Questions (DHT, Progesterone, Fin, etc)
- looking for a pure high molecular weight hyaluronic acid for scalp after microneedling
- New molecule PP405 vs exercise
- mallia therapeutics 8T3 scd83 molecule for ffa/lpp mainly and aga
- UCLA scientists found a molecule — PP405 — that wakes up sleeping hair follicles and tells them, “Do your job.”
- Pyrilutamide ,the molecule’s true nature
- What is the chance that the pp405 molecule gets leaked to the grey market in phase 3?
Learn
— no results
Try a deeper search in learn →